These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27053454)

  • 41. Supratherapeutic doses of angiotensin receptor blockers to decrease proteinuria in patients with chronic kidney disease.
    Palmer BF
    Am J Nephrol; 2008; 28(3):381-90. PubMed ID: 18063856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic inhibition of the renin angiotensin aldosterone system.
    Laight DW
    Expert Opin Ther Pat; 2009 Jun; 19(6):753-9. PubMed ID: 19456280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal disease.
    Slagman MC; Navis G; Laverman GD
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):140-52. PubMed ID: 20051849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease.
    McCullough PA; Verrill TA
    Postgrad Med; 2010 Mar; 122(2):25-34. PubMed ID: 20203453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calibrating the impact of dual RAAS blockade on the heart and the kidney - balancing risks and benefits.
    Ziff OJ; Covic A; Goldsmith D
    Int J Clin Pract; 2016 Jul; 70(7):537-53. PubMed ID: 27278080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renin-angiotensin-aldosterone system blockade in chronic kidney disease: current strategies and a look ahead.
    Viazzi F; Bonino B; Cappadona F; Pontremoli R
    Intern Emerg Med; 2016 Aug; 11(5):627-35. PubMed ID: 26984204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
    Ripley E
    Am Heart J; 2009 Jun; 157(6 Suppl):S7-S16. PubMed ID: 19450722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sodium intake, RAAS-blockade and progressive renal disease.
    de Borst MH; Navis G
    Pharmacol Res; 2016 May; 107():344-351. PubMed ID: 27041482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.
    Bomback AS; Toto R
    Am J Hypertens; 2009 Oct; 22(10):1032-40. PubMed ID: 19661925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Underprescription of renin-angiotensin system blockers in moderate to severe chronic kidney disease.
    Shirazian S; Grant CD; Mujeeb S; Sharif S; Kumari P; Bhagat M; Mattana J
    Am J Med Sci; 2015 Jun; 349(6):510-5. PubMed ID: 26030613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination therapy in chronic kidney disease?
    Juncos LI; Caputo J
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):147-52. PubMed ID: 25882750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chronic renal insufficiency and cardiovascular disease].
    Charriere S; Rognant N; Chiche F; Cremer A; Deray G; Priou M
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):40-52. PubMed ID: 18937921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The next generation of therapeutics for chronic kidney disease.
    Breyer MD; Susztak K
    Nat Rev Drug Discov; 2016 Aug; 15(8):568-88. PubMed ID: 27230798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blockers of the renin-angiotensin-aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases!
    Waeber B
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):216. PubMed ID: 22389390
    [No Abstract]   [Full Text] [Related]  

  • 56. The importance of renin-angiotensin blockade in patients with cardio-renal disease.
    Benavente D; Chue CD; Ferro CJ
    J Ren Care; 2010 May; 36 Suppl 1():97-105. PubMed ID: 20586905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny.
    Gentile G; Remuzzi G; Ruggenenti P
    Nephron; 2015; 129(1):39-41. PubMed ID: 25531311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renin-Angiotensin System Control for Chronic Kidney Disease Patients Undergoing Coronary Surgery.
    Yoshitake I; Sezai A; Hata M; Osaka S; Kimura H; Hata H; Shiono M
    Ann Thorac Cardiovasc Surg; 2016 Oct; 22(5):291-297. PubMed ID: 27558882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiorenal disease development under chronic renin-angiotensin-aldosterone system suppression.
    Sarafidis PA; Ruilope LM
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):217-9. PubMed ID: 22389391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.